There is now overwhelming evidence that modern antihypertensive management reduces death, stroke and cardiovascular disease (CVD) events. 1 However, this can only occur if management is instituted and blood pressure targets achieved. Recent data from AusDiab, showed a high prevalence of untreated hypertension and modifiable CVD risk factors across Australia. 2 Rural Australia experiences substantially higher hospital separations for stroke and CVD and death rates from CVD when compared with metropolitan cities. 3, 4 The reasons for this are unclear. Selfreported CVD risk factors such as diabetes, hypertension, hypercholesterolaemia and obesity are patchily higher, 3 but very little detailed data exist investigating the quality of risk factor management. We have therefore investigated the management of a major CVD risk factor, hypertension, in three randomly selected general practices in rural Victoria.
The practices, of comparable size, with a total of 12 general practitioners were randomly selected to be included in the review. One practice was situated in the regional centre (population 34 000) and two practices 50-100 km from the centre (populations 5000-10 000). The study was approved by the local ethics committee. Patients were informed of the chart review through posters displayed in prominent positions in the participating general practices. In spite of this, participating GPs were reluctant for the area and practices involved to be identified and hence all information that could identify the practitioners was removed.
The chart review used a standard form developed from a diabetes study. 5 Patients were included in the study if a diagnosis of hypertension was recorded and seen in the previous 12 months. The basis for the diagnosis was not reviewed as this was generally not recorded. Patients with elevated blood pressure suggesting undiagnosed hypertension were not included. The highest blood pressure in each quarter was recorded where more than one measurement occurred during that period of time. The date of diagnosis of hypertension was difficult to identify systematically and has not been analysed. The classification of hypertension followed Australian 1999 National Heart Foundation guidelines 6 (based upon the 1999 WHO-ISH guidelines). 7 Severity of hypertension was defined as mild (140-159/90-99 mmHg), moderate (160-179/100-110 mmHg) or severe (X180/110 mmHg). Data were analysed using SPSS v12 (SPSS Inc, Chicago, IL, USA). No subjects were included more than once. Results shown are mean s.d. or frequencies (percentages). Statistical significance was taken at the 5% level and all tests are two-tailed. Discrete variables were compared using w 2 test and continuous variables using analysis of variance with adjustment for covariates by either Mantel Haenszel or analysis of covariance.
A diagnosis of hypertension was recorded in the notes in 3134 patients. The majority of patients (1651, 52.7%) were aged X65 years, with 10.6% aged o45 years (mean age 64715 years; 45% male); 53.5% lived in the regional centre. Comorbidity included diabetes mellitus (12.6%), current smoking (16.8%), renal disease (2.2%; 0.1% on dialysis), atrial fibrillation (5.2%), cardiac failure (3.2%), past stroke or transient ischaemic attack (3.2%) and past myocardial infarction (4.5%); 7.9% had been hospitalised in the past 12 months, 1.2% had had past vascular surgery, 3.0% past coronary artery bypass grafting and 1.9% past percutaneous coronary angioplasty. Table 1 lists the recorded hypertension management among the patients. Among those on antihypertensive agents 28.7, 43.0, 20.3 and 8.0% had controlled, mild, moderate or severe hypertension, respectively.
Patients living in the regional centre (vs others) were most likely to have had quarterly assessments (14.4 vs 11.3%; P ¼ 0.01), had lower systolic but higher diastolic blood pressure (145718/84710 vs 148720/82710 mmHg; Po0.001) and were less likely to have moderate or severe elevation of blood pressure (24.3 vs 28.0%; P ¼ 0.019). Women were more likely to have quarterly blood pressure measurements (14.0 vs 11.6%; P ¼ 0.05), had higher systolic, but lower diastolic blood pressure (146718/8279 vs 143717/83710 mmHg; Po0.001/P ¼ 0.001). Women were less likely to have their lipids checked (4.6 vs 7.4%; P ¼ 0.001), more likely to receive beta-blockers (15.3 vs 12.7%; P ¼ 0.032) and diuretics (23.6 vs 17.2%; Po0.001), but less likely to receive ACE inhibitors (35.7 vs 39.6%; P ¼ 0.024), aspirin (16.6 vs 19.7%) and statins (18.0 vs 21.3%; P ¼ 0.019). The number of antihypertensive medications increased with age (r ¼ 0.264, Po0.001). Among the 405 patients with quarterly measures, the blood pressure trended upwards over the year (145720/8079 to 148722/ 82710 mmHg; P ¼ 0.031/0.007).
The proportion of treated patients with mild, moderate and severe elevations in blood pressure in these three randomly selected practices was greater than in the national Australian study (AusDiab: 35.7, 17.7, 6.9%, respectively). 2 The proportion with controlled hypertension (taken as o140/90-28.7%) while on medication, by the standard at the time 6, 7 was relatively low when compared with controlled hypertension rates (while on medication) of 39.7% in AusDiab, 2 53.1% in the latest NHANES 8 and 33%
in suburban Adelaide. 9 Whether this low level of hypertension treatment and control in the study area reflects experience in other parts of rural Australia is unclear, but if so, this would help explain the excess morbidity and mortality shown in national data. 3, 4 Rural general practitioners in Western Australia do report a significantly longer follow-up time between consultations and targeting a higher blood pressure. 10 This study was unable to assess the extent of underdiagnosis of hypertension, so these data probably underestimate the magnitude of the problem. Similarly, this study could not investigate the causes of undertreatment such as lack of guideline awareness and patient adherence. While patient factors cannot be excluded, in a setting of worsening in diastolic blood pressure we feel the most likely explanation is a lack of aggression in treating hypertension overall. Patients attending specialist hypertension clinics, where more aggressive attention to hypertension is provided, can achieve systolic and diastolic goals in 63 and 86% of cases, respectively. 11 Such support was not possible in the study area, which had a shortage of physicians as well as general practitioners. 12 In areas of reduced primary care access, guideline modification (eg lower thresholds for commencing pharmacotherapy and greater use of home blood pressure monitoring) should be considered. 
